166 related articles for article (PubMed ID: 30944006)
1. Anti-H7N9 avian influenza A virus activity of interferon in pseudostratified human airway epithelium cell cultures.
Chen AJ; Dong J; Yuan XH; Bo H; Li SZ; Wang C; Duan ZJ; Zheng LS
Virol J; 2019 Apr; 16(1):44. PubMed ID: 30944006
[TBL] [Abstract][Full Text] [Related]
2. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
3. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures.
Hui KPY; Ching RHH; Chan SKH; Nicholls JM; Sachs N; Clevers H; Peiris JSM; Chan MCW
Lancet Respir Med; 2018 Nov; 6(11):846-854. PubMed ID: 30001996
[TBL] [Abstract][Full Text] [Related]
4. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
[TBL] [Abstract][Full Text] [Related]
5. IFN-λ1 in CHO cells: its expression and biological activity.
Yuan WM; Zhang WJ; Ma FL; Li JS; Zhang Q; Zheng LS
Cell Mol Biol Lett; 2017; 22():26. PubMed ID: 29213292
[TBL] [Abstract][Full Text] [Related]
6. Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus.
To KK; Lau CC; Woo PC; Lau SK; Chan JF; Chan KH; Zhang AJ; Chen H; Yuen KY
Virol J; 2016 Mar; 13():42. PubMed ID: 26975414
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment of the Tropism and Pathogenesis of the Highly Pathogenic Avian Influenza A/H7N9 Virus Using Ex Vivo and In Vitro Cultures of Human Respiratory Tract.
Chan LLY; Hui KPY; Kuok DIT; Bui CHT; Ng KC; Mok CKP; Yang ZF; Guan W; Poon LLM; Zhong N; Peiris JSM; Nicholls JM; Chan MCW
J Infect Dis; 2019 Jul; 220(4):578-588. PubMed ID: 31001638
[TBL] [Abstract][Full Text] [Related]
8. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus.
Zeng H; Belser JA; Goldsmith CS; Gustin KM; Veguilla V; Katz JM; Tumpey TM
J Virol; 2015 Apr; 89(8):4655-67. PubMed ID: 25673714
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
[TBL] [Abstract][Full Text] [Related]
10. Prokaryotic expression of soluble IFN-λ1 recombinant protein with cold-shock system.
Ren L; Meng X; Sun J; Shao X; Shao M; Wang S; Li Z; Chen Y
Protein Expr Purif; 2024 Mar; 215():106413. PubMed ID: 38065246
[TBL] [Abstract][Full Text] [Related]
11. Interferon lambda inhibits dengue virus replication in epithelial cells.
Palma-Ocampo HK; Flores-Alonso JC; Vallejo-Ruiz V; Reyes-Leyva J; Flores-Mendoza L; Herrera-Camacho I; Rosas-Murrieta NH; Santos-López G
Virol J; 2015 Sep; 12():150. PubMed ID: 26411318
[TBL] [Abstract][Full Text] [Related]
12. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
Liu Q; Ma J; Strayer DR; Mitchell WM; Carter WA; Ma W; Richt JA
Expert Rev Anti Infect Ther; 2014 Feb; 12(2):165-9. PubMed ID: 24350808
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
Ilyushina NA; Lugovtsev VY; Samsonova AP; Sheikh FG; Bovin NV; Donnelly RP
PLoS One; 2017; 12(7):e0181999. PubMed ID: 28750037
[TBL] [Abstract][Full Text] [Related]
14. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
[TBL] [Abstract][Full Text] [Related]
16. Tropism and Infectivity of a Seasonal A(H1N1) and a Highly Pathogenic Avian A(H5N1) Influenza Virus in Primary Differentiated Ferret Nasal Epithelial Cell Cultures.
Zeng H; Goldsmith CS; Kumar A; Belser JA; Sun X; Pappas C; Brock N; Bai Y; Levine M; Tumpey TM; Maines TR
J Virol; 2019 May; 93(10):. PubMed ID: 30814288
[TBL] [Abstract][Full Text] [Related]
17. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Modeling of SARS-CoV-2 Infection of
Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J
mBio; 2020 Nov; 11(6):. PubMed ID: 33158999
[TBL] [Abstract][Full Text] [Related]
19. Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor.
Li C; Li C; Zhang AJ; To KK; Lee AC; Zhu H; Wu HW; Chan JF; Chen H; Hung IF; Li L; Yuen KY
PLoS One; 2014; 9(9):e107966. PubMed ID: 25232731
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
